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Abstract 
A fusion protein (FP) comprised of the RNase A S-peptide and human epidermal growth factor was shown to form a stable noncovalent catalytically 
active complex with the RNase A S-protein at a stoichiometric ratio 1: 1 with Kdlss = 5.0 x lo-’ M. The S-protein complex with FP exhibits the 
pyrimidine specificity toward substrates in both reactions catalyzed by RNase S, transesterification and hydrolysis. The fusion protein can be 
determined specifically and quantitatively in the presence of S-protein by RNase activity assays. The possibility of effective purification of S-peptide- 
containing proteins by affinity chromatography on an S-protein-Sepharose column has been demonstrated. 
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1. Introduction 
The problem of ‘modular activity’ of fused proteins 
has both a theoretical and an obviously practical signifi- 
cance. The present work deals with the study of the 
S-peptide recognition by S-protein when the former is 
inserted into a recombinant protein, containing the 
human epidermal growth factor sequence (hEGF). Lim- 
ited proteolysis of pancreatic ribonuclease (RNase A) by 
subtilisin results in cleavage of a peptide bond (20-21) 
and fragments (I-20)-S-peptide and (21-124)-S-protein 
are held together by noncovalent interactions [l]. The 
modified protein called RNase S, retains the catalytic 
properties of RNase A. Acid treatment of RNase S re- 
sults in formation of catalytically inactive components. 
At neutral pH restoration of the catalytically active com- 
plex, RNase S’, takes place. The RNase S crystal struc- 
ture study shows that the C-terminus of S-peptide and 
N-terminus of S-protein of RNase S are at a distance of 
27 A from each other (Fig. 1) [2]. Consequently, one may 
*Corresponding author. Fax: (7) (095) 135 14 05. 
Abbreviations: RNase A, pancreatic ribonuclease (EC 3.1.27.5); hEGF, 
human epidermal growth factor; FP-fusion protein made up of one 
molecule of hEGF with one molecule of S-peptide. 
Footnote: The main results of this work were reported at the Interna- 
tional Conference ‘Modem Enzymology: Problems and Trends’, 
(1992). St-Peterburg; at the 3rd International Meeting ‘Ribonucleases: 
Chemistry, Biology, Biotechnology’ (1993), Capri, Italy. 
assume that the attachment of a protein to the C-termi- 
nus of the S-peptide should not interfere with its specific 
interaction with the S-protein. However, the catalytic 
properties of a conjugate (if any) might be affected. The 
fusion protein hEGF (53 amino acids) with one molecule 
of S-peptide- was obtained using conventional DNA 
manipulations techniques [3]. 
2. Materials and methods 
2. I. Materials 
The earlier described technique [3] was used to prepare a crude 
extract (periplasmic fraction) of E. coli cells transformed by a plasmid, 
carrying the FP encoding gene. S-protein was obtained by RNase A 
(Sigma, USA) selective hydrolysis with subtilisin according to [4]. Ho- 
mopolymers of ribonucleotides and 2’,3’-nucleoside cyclophosphates 
were from Sigma; yeast RNA and cyanogen bromide were from Serva; 
Sepharose CL-4B, and the LMW Calibration Kit were from Pharmacia 
LKB Biotechnology Inc. The electrophoretically homogeneous FP and 
polyclonal antibodies against hEGF were kindly supplied by A.V. 
Azhayev and N.V. Batchicova. The conjugate S-protein-Sepharose 4B 
was obtained as described [5]. 
2.2. Purification of fusion protein (FP) 
30 ml of periplasmic fraction preliminarily diluted by half with 0.1 M 
ammonium-acetate buffer, pH 6.0, were applied to a column (0.5 x 4 
cm), filled with S-protein-Sepharose CL4B (total S-protein content 
7 mg) and equilibrated with the same buffer. The column was washed 
with the equilibration buffer containing 2.0 M NaCl. Elution of FP was 
performed with 1% acetic acid at the flow rate of 16 ml/h, 2, = 280 nm. 
2.3. Determination of fusion protein concentration 
The concentration of electrophoretically homogeneous FP was deter- 
mmed by Bradford’s method [6]. Quantitative determination of FP 
concentration in the crude extract was carried out using the RNA or 
2’,3’-cCMP hydrolysis initial rate dependence upon the purified FP 
concentration. 
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2.4. SDS-gel electrophoresis 
Electrophoresis was performed in a 15% polyacrylamide gel in the 
presence of 0.1% sodium dodecyl sulfate using the buffer system of 
Laemmli [7]. Band positions were determined by using a Molecular 
Dynamics Computing Densitometer. 
2.5. Enzyme activity assays of S-protein-FP complex 
The RNase activity was determined by a modification of the method 
of Kunitz (yeast RNA hydrolysis) [8] or according to Crook et al. 
(2’,3’-cCMP as substrate) [9]. using a constant concentration of S- 
protein and various concentrations of S-peptide or FP. The evaluation 
of the S-protein-FP complex dissociation constant X;,, is based on the 
applicatjon of the mass action law 181. 
2.6. determination of the complex sto~c~iometry b.v HPLC 
An excess of S-protein was added to FP and the mixture was kept 
overnight at pH 7.0, 4°C. Aliquots (20 yl), containing about 40 fig of 
protein were-applied to a D&orb 4Od DIOL (0.8 x25 cm) column 
(Elsika. Russia). Elution was nerformed with 25 ml of HEPES (Na) 
buffer, pH 7.3, at a flow rate of’1 ml/min, 20°C, 2 = 280 nm. A mixture 
of standard proteins was separated under the same conditions as a 
reference. 
2.7. Immunoassay 
Determination of hEGF antigens in peripiasmic fractions and FP 
samples was carried out using the classic indirect ELISA. 
3. Results and discussion 
S-peptide in a neutral aqueous solution is known to 
form a specific noncovalent complex with S-protein 
(Kd,ss = 1O-5-lO-g M). The catalytic properties this com- 
plex are practically the same as those of a native enzyme 
[1,8,10,1 I]. One may expect hat the S-protein interaction 
with the fusion protein (FP) would result in formation 
of a catalytically competent complex, resembling by its 
properties those of RNase S’. The FP addition to S- 
protein gives rise to restoration of the specific enzyme 
activity of RNase S’. It was demonstrated that for S- 
protein or FP alone no detectable nzymatic activity was 
found under the same conditions. Consequently, one 
may conclude that the S-peptide attached to hEGF, in- 
teracts with S-protein forming a functionally productive 
noncovalent complex. 
3.1. Stoichiometry of S-protein-FP complex 
The FP mixture with an excess of S-protein has been 
separated by HPLC into two main components. The first 
component corresponds to a polypeptide with the molec- 
ular mass of about 21-22 kDa (Fig. 2, peak i), and the 
second one to a polypeptide of 13-l 5 kDa (Fig. 2, peak 
2). The components were collected separately, concen- 
trated and tested for ribonuclease activity. Component 
1 was found to be active, whereas component 2 was 
devoid of it, but the activity appeared after addition of 
S-peptide to the solution. These results allow us to iden- 
tify the first component as an FP complex with S-protein 
(1: 1) and the second one as S-protein. Besides these, a 
small amount of FP (< 5%) was detected. 
3.2. Properties of the complex formed by FP with 
S-protein 
The FP complex with S-protein is as effective in 2’,3’- 
cCMP hydrolysis as RNase S’, whereas 2’,3’-CAMP is 
resistant to both RNase S’ and the complex (Table 1). 
Although catalytic properties of the complex are rather 
close to those of RNase S’ there are several distinctions 
between them. For example, practically complete hydrol- 
ysis of poly(C) by RNase S’ requires two hours, whereas 
a significant amount of 2’,3’-cCMP has been detected in 
the reaction mixture even after two days of incubation 
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Fig. 1. Schematic representation of a molecular three-dimensional structure of RNase S 
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Fig. 2. Determination of stoichiometry between S-protein and FP by the size exclusion HPLC on the Diasorb 400 DIOL column. Separation of the 
FP-S-protein complex (1) and S-protein (2). 
in the presence of the complex. When poly(A) was incu- 
bated in the presence of RNase S’ the hydrolysis prod- 
ucts (olygonucleotides, 2’,3’-CAMP, 3’-AMP) appeared 
already the next day. Poly(A) was found to be stable for 
two days in the presence of the complex and only then 
traces of oligonucleotides and 2’,3’-CAMP appeared. 
One may assume that such differences are due to inacti- 
vation of the complex. In spite of those differences, the 
results indicate that pyrimidine specificity of RNase A 
was still retained by the complex. 
Dissociation (binding) constants, free binding energies 
(dG”) and relative catalytic activities of the complex and 
RNase S’ were determined (Fig. 3, Table 2). It is of 
interest that the maximum rate value is the same pro- 
vided that S-protein is saturated with S-peptide. The 
results were shown to be reproducible with various pol- 
ypeptide preparations. 
3.3. The perspectives of application 
The results obtained suggest certain prospects for their 
practical applications. The first self-evident consequence 
would be to use affinity chromatography with a matrix, 
containing immobilized S-protein for purification of FP 
with S-peptide attached to its N-terminal part. The valid- 
ity of such an approach was demonstrated by FP isola- 
tion from the crude extract using affinity chromatogra- 
phy on the S-protein-Sepharose column. Fig. 4 shows 
SDS-PAGE separation of hEGF and FP from periplas- 
mic fractions. The estimated FP molecular mass value 
9.1 kDa is close to that calculated from the amino acid 
composition (8.8 kDa). Eluted from the column, FP gave 
a single band with the same molecular mass value on 
SDS-PAGE (data not shown). Recently the FP construc- 
tion of /I-galactosidase with the truncated S-peptide 
(1-15 amino acid residues) has been reported [13]. This 
Table 1 
TLC analysis of a mixture resulted from substrates treatment with RNase S’ and FP-S-protein complex 
RNase S Complex FP-S-protein 
Substrate Time of reaction Products identified Time of reaction Products identified 
2’,3’-cCMP 
2’,3’-CAMP 
POlY(C) 
20 min 
24 h 
3h 
24 h 
48 h 
30 min 
Poly(A) 
2h 
30 min 
24 h 
3’CMP (50%) 
3’CMP (100%) 
none 
none 
traces of 3’-AMP 
2’,3’-cCMP (50%) 
and 3’-CMP (50%) 
3’-CMP (100%) 
none 
traces of 
ohgonucleotides 
and 2’,3’-CAMP 
20 mm 
24 h 
20 min 
24 h 
48 h 
60 min 
60 min 
48 h 
3’-CMP (- 50%) 
3’-CMP (100%) 
none 
none 
traces of 3’-AMP 
2’,3’-cCMP (- 50%) 
and 3’-CMP (- 50%) 
none 
traces of 
oligonucleotides 
and 2’.3’-CAMP 
Conditions: 0.1 M Tris-HCl, pH 7.0, 0.1 M NaCI. 
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Table 2 
Binding properties and activities of S-protein-S-peptide system at pH 
5.0, 20°C. (substrate-RNA) 
Peptide Kdljs Kb - AG” ApmaX I Asma’ 
W W’) (kcaVmo1) 
S-peptlde 5.7 x lo-8 1.8 x 10’ 10.2 1.0 
FP 5.0 x lo-’ 2.0 x lo6 8.8 1.0 
A?, maximum activity of RNase S’ at the S-protein saturation with 
S-peptide. Ar‘. maximum activity of FP-S-protein complex. 
study has shown that the interaction between the S-pep- 
tide portion of FP and immobilized S-protein allowed for 
affinity purification of FP and quantitative determina- 
tion of FP concentration by the restoration of RNase 
activity after activation with S-protein. 
Thus, S-protein recognize S-peptide even when the 
latter is incorporated into the fusion protein. It should 
be noted that, according to the immunoassay, hEGF in 
the FP retains properties of native hEGF. This means 
that the S-peptide fragment of the hybrid protein is still 
available for interaction with S-protein even when the 
polypeptide chain acquires the conformational charac- 
teristic of native hEGF. 
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Fig. 3. The enzymatic activity development resulted from addition of 
either S-peptide (0) or the fusion protein (0) to S-protein. Conditions: 
0.1% solution of RNA in 0.1 M NaAc. pH 5.0, S-protein concentration: 
3.0 x lo-’ M, 20°C. 
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Fig. 4. SDS-acrylamide gel electrophoresis of crude extract containing 
hEGF (lane 2) and fusion protein (lane 3). Lanes 1 and 4, LMW 
markers (kDa): 17.2; 14.6; 8.2; 6.38; 2.56 
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